Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective StudyMarco Galluzzo, Pietro Rubegni, Marina Talamonti et al.|Journal of Clinical Medicine|2024Cited by 7